drugset / Trial / NCT05035576
A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine both the magnitude and duration of viral load (copies/mL) reduction after a single dose of OPN-019. The variability associated with viral counts will be utilized to inform the study design of future studies.
Timeline
- Start
- 2021-09-01
- Primary completion
- 2021-11-30
- Completion
- 2021-11-30
Outcome
Outcome not reported
Stopped (Business): “Sponsor Decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | OPN-019 | Unknown | 400 mg | Intranasal |